These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7471612)

  • 1. Sotalol kinetics in renal insufficiency.
    Blair AD; Burgess ED; Maxwell BM; Cutler RE
    Clin Pharmacol Ther; 1981 Apr; 29(4):457-63. PubMed ID: 7471612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.
    Tjandramaga TB; Verbeeck R; Thomas J; Verbesselt R; Verberckmoes R; Schepper PJ
    Br J Clin Pharmacol; 1976 Apr; 3(2):259-65. PubMed ID: 973960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceforanide kinetics in renal insufficiency.
    Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isepamicin disposition in subjects with various degrees of renal function.
    Halstenson CE; Kelloway JS; Affrime MB; Lin CC; Teal MA; Shapiro BE; Awni WM
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2382-7. PubMed ID: 1804011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral flecainide pharmacokinetics in patients with impaired renal function.
    Forland SC; Burgess E; Blair AD; Cutler RE; Kvam DC; Weeks CE; Fox JM; Conard GJ
    J Clin Pharmacol; 1988 Mar; 28(3):259-67. PubMed ID: 3129455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renal dysfunction on the pharmacokinetics of loracarbef.
    Therasse DG; Farlow DS; Davidson RL; Quadracci LJ; Hatcher BL; Cerimele BJ; DeSante KA
    Clin Pharmacol Ther; 1993 Sep; 54(3):311-6. PubMed ID: 8375126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.
    Humbert G; Fillastre JP; Leroy A; Godin M; Van Winzum C
    Rev Infect Dis; 1979; 1(1):118-26. PubMed ID: 318213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR; Abraham PA; Halstenson CE; Keane WF
    Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bretylium kinetics in renal insufficiency.
    Josselson J; Narang PK; Adir J; Yacobi A; Sadler JH
    Clin Pharmacol Ther; 1983 Feb; 33(2):144-50. PubMed ID: 6822027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.
    Horadam VW; Sharp JG; Smilack JD; McAnalley BH; Garriott JC; Stephens MK; Prati RC; Brater DC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):454-8. PubMed ID: 7212501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal failure, hemodialysis, and nafcillin kinetics.
    Rudnick M; Morrison G; Walker B; Singer I
    Clin Pharmacol Ther; 1976 Oct; 20(4):413-23. PubMed ID: 975716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
    Viotte G; Leroy A; Godin M; Fillastre JP
    Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition kinetics of disopyramide in patients with renal insufficiency.
    Shen DD; Cunningham JL; Shudo I; Azarnoff DL
    Biopharm Drug Dispos; 1980; 1(3):133-40. PubMed ID: 7448340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination kinetics of captopril in patients with renal failure.
    Duchin KL; Pierides AM; Heald A; Singhvi SM; Rommel AJ
    Kidney Int; 1984 Jun; 25(6):942-7. PubMed ID: 6381858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a fixed combination of sotalol and hydrochlorothiazide in hypertensive patients with moderate renal insufficiency.
    Kher A; Fillastre JP; Fourtillan JB; Lefebvre MA; Ingrand I
    Eur J Clin Pharmacol; 1984; 27(3):361-2. PubMed ID: 6510465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC; Pue MA; Freed MI; Audet PR; Fairless A; Ilson BE; Zariffa N; Jorkasky DK
    Clin Pharmacol Ther; 1994 Apr; 55(4):418-26. PubMed ID: 8162668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.